Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 3Breast Neoplasms 2Stress Disorders, Post-Traumatic 1Sedentary Behavior 1Pulmonary Disease, Chronic Obstructive 1Prostate Adenocarcinoma 1Pain 1Overweight 1Obesity 1Motor Activity 1Melanoma 1Lung Neoplasms 1Leukemia 1Digestive System Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Arthralgia 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 51Ipilimumab 49Cyclophosphamide 43Nivolumab 40aldesleukin 30Interleukin-2 23Vemurafenib 20fludarabine 19Temozolomide 18fludarabine phosphate 15dabrafenib 15trametinib 12Radiosurgery 10Dacarbazine 10CTLA-4 Antigen 10spartalizumab 9cobimetinib 9binimetinib 9Radiotherapy 9poly ICLC 7encorafenib 7Paclitaxel 7atezolizumab 6Introns 6Biopsy 6montanide ISA 51 5Carboplatin 5epacadostat 4MART-1 Antigen 4Interferon alpha-2 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Melanoma × Educational Status × Clear all
NCT05388851 2025-06-22

Education for Prevention of Melanoma in Hispanic Populations

Mayo Clinic

Phase 2 Terminated
145 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡